Interv Akut Kardiol. 2020;19(1):55-59 | DOI: 10.36290/kar.2019.053
Infective endocarditis in transcatheter aortic valve implantation
- Kardiocentrum, Kardiochirurgická klinika a I. interní Kardio-angiologická klinika, Fakultní nemocnice, Hradec Králové
Since the first transcatheter aortic valve implantation (TAVI) this method has spread out widely. Originally, this method was indicated for inoperable and high-risk patients; nowadays it has FDA approval even for low-risk patients. As any invasive procedure, TAVI is also associated with complications, including prosthetic valve endocarditis (TAVI-IE). The incidence of TAVI-IE is reported to be 0.2-3.4 % and its mortality up to 67 % at two years after confirmation of the diagnosis. The aim of this article is to review current knowledge on this serious complication.
Keywords: prosthetic valve endocarditis, TAVI, TAVI-IE, antibiotic prophylaxis, vegetation, periannular complication, baloon-expandable valve, self-expandable valve, paravalvular regurgitation.
Received: November 21, 2019; Revised: December 27, 2019; Accepted: December 29, 2019; Published: June 1, 2020 Show citation
